|
|
Volumn 6, Issue 1, 2002, Pages 19-24
|
|
New agents and future directions in biotherapy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL PRODUCT;
MONOCLONAL ANTIBODY;
NEW DRUG;
RITUXIMAB;
THALIDOMIDE;
TRASTUZUMAB;
FEMALE;
FORECASTING;
HUMAN;
MALE;
METHODOLOGY;
NEOPLASM;
RADIOIMMUNOTHERAPY;
REVIEW;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL PRODUCTS;
DRUGS, INVESTIGATIONAL;
FEMALE;
FORECASTING;
HUMANS;
MALE;
NEOPLASMS;
RADIOIMMUNOTHERAPY;
SENSITIVITY AND SPECIFICITY;
THALIDOMIDE;
TREATMENT OUTCOME;
|
|
EID: 0036362333
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/02.CJON.19-24 Document Type: Review |
|
Times cited : (4)
|
|
References (33)
|
